362 related articles for article (PubMed ID: 26662962)
41. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells.
Zhou L; Park J; Jang KY; Park HS; Wagle S; Yang KH; Lee KB; Park BH; Kim JR
Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684
[TBL] [Abstract][Full Text] [Related]
42. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
[TBL] [Abstract][Full Text] [Related]
43. Upregulated LEPRE1 correlates with poor outcome and its knockdown attenuates cells proliferation, migration and invasion in osteosarcoma.
Huang Z; Wang Q; Wang Y; Zhao L; Cao Z; Cui C; Yu D; Liu B
Anticancer Drugs; 2020 Apr; 31(4):326-332. PubMed ID: 32197005
[TBL] [Abstract][Full Text] [Related]
44. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of gelsolin reduces the proliferation and invasion of colon carcinoma cells.
Li WX; Yang MX; Hong XQ; Dong TG; Yi T; Lin SL; Qin XY; Niu WX
Mol Med Rep; 2016 Oct; 14(4):3059-65. PubMed ID: 27573444
[TBL] [Abstract][Full Text] [Related]
46. MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.
Ren Z; He M; Shen T; Wang K; Meng Q; Chen X; Zhou L; Han Y; Ji C; Liu S; Fu Q
Cancer Biol Ther; 2020; 21(3):231-240. PubMed ID: 31718519
[TBL] [Abstract][Full Text] [Related]
47.
Kidani T; Yasuda R; Miyawaki J; Oshima Y; Miura H; Masuno H
Anticancer Res; 2017 Apr; 37(4):1711-1722. PubMed ID: 28373433
[TBL] [Abstract][Full Text] [Related]
48. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
[TBL] [Abstract][Full Text] [Related]
49. Role of miR-647 in human gastric cancer suppression.
Cao W; Wei W; Zhan Z; Xie D; Xie Y; Xiao Q
Oncol Rep; 2017 Mar; 37(3):1401-1411. PubMed ID: 28098914
[TBL] [Abstract][Full Text] [Related]
50. Glabridin inhibits osteosarcoma migration and invasion via blocking the p38- and JNK-mediated CREB-AP1 complexes formation.
Jie Z; Xie Z; Zhao X; Sun X; Yu H; Pan X; Shen S; Qin A; Fang X; Fan S
J Cell Physiol; 2019 Apr; 234(4):4167-4178. PubMed ID: 30146723
[TBL] [Abstract][Full Text] [Related]
51. Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway.
Hao L; Liao Q; Tang Q; Deng H; Chen L
Biochem Biophys Res Commun; 2016 Feb; 470(3):643-649. PubMed ID: 26797271
[TBL] [Abstract][Full Text] [Related]
52. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA‑106a regulates the proliferation and invasion of human osteosarcoma cells by targeting VNN2.
Chen Y; Huang T; Yang X; Liu C; Li P; Wang Z; Zhi S
Oncol Rep; 2018 Oct; 40(4):2251-2259. PubMed ID: 30066949
[TBL] [Abstract][Full Text] [Related]
54. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro.
Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL
Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910
[TBL] [Abstract][Full Text] [Related]
55. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
[TBL] [Abstract][Full Text] [Related]
56. HER4 promotes the growth and metastasis of osteosarcoma via the PI3K/AKT pathway.
Li X; Huang Q; Wang S; Huang Z; Yu F; Lin J
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):345-362. PubMed ID: 32181480
[TBL] [Abstract][Full Text] [Related]
57. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways.
Shijie L; Zhen P; Kang Q; Hua G; Qingcheng Y; Dongdong C
Clin Transl Med; 2021 Jun; 11(6):e377. PubMed ID: 34185412
[TBL] [Abstract][Full Text] [Related]
58. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
Li T; Xiao Y; Huang T
Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
[TBL] [Abstract][Full Text] [Related]
59. Berberine affects osteosarcoma via downregulating the caspase-1/IL-1β signaling axis.
Jin H; Jin X; Cao B; Wang W
Oncol Rep; 2017 Feb; 37(2):729-736. PubMed ID: 28000894
[TBL] [Abstract][Full Text] [Related]
60. Overexpressed CISD2 has prognostic value in human gastric cancer and promotes gastric cancer cell proliferation and tumorigenesis via AKT signaling pathway.
Wang L; Ouyang F; Liu X; Wu S; Wu HM; Xu Y; Wang B; Zhu J; Xu X; Zhang L
Oncotarget; 2016 Jan; 7(4):3791-805. PubMed ID: 26565812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
